LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.

Proximal hypoglossal nerve stimulation offers a clinically significant response for adults with obstructive sleep apnea.

A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...

In a recent trial, 60 percent of patients using the device had fewer breathing interruptions and less daytime fatigue. For ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an old drug just might help people with the condition, recent trial data shows.

The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...

People who experience sleep apnea may be more likely to also have memory or thinking problems, according to a preliminary study. The study shows a positive association but did not determine whether ...

Q: Should I be worried about obstructive sleep apnea? Obstructive sleep apnea is estimated to affect 25 million Americans or ...

One study showed that losing weight is unlikely to eliminate sleep apnea. Overweight and obese patients can significantly improve sleep apnea by losing approximately 10% of their body weight—but even ...

The sixth developer beta of iOS 18.1 is now available for all compatible iPhone models. Here's everything you need to know about the update and the features it introduces. The company's sixth and most ...